Showing results (61-70 of 105) with videos related to

Sort By:
Pageof 11
Biorxiv : the Preprint Server for Biology|June 25, 2020
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric virusesFabian Schmidt, Yiska Weisblum, Frauke Muecksch, et al.
Medrxiv : the Preprint Server for Health Sciences|August 19, 2022
Antibody feedback regulation of memory B cell development in SARS-CoV-2 mRNA vaccinationDennis Schaefer-Babajew, Zijun Wang, Frauke Muecksch, et al.
The Journal of Experimental Medicine|November 12, 2014
Enhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variantsFlorian Klein, Lilian Nogueira, Yoshiaki Nishimura, et al.
The Journal of Experimental Medicine|June 27, 2023
Memory B cell development elicited by mRNA booster vaccinations in the elderlyZijun Wang, Frauke Muecksch, Raphael Raspe, et al.
Elife|October 28, 2020
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variantsYiska Weisblum, Fabian Schmidt, Fengwen Zhang, et al.
Cell|September 10, 2016
Sequential Immunization Elicits Broadly Neutralizing Anti-HIV-1 Antibodies in Ig Knockin MiceAmelia Escolano, Jon M Steichen, Pia Dosenovic, et al.
The Journal of Experimental Medicine|August 27, 2014
Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaquesMasashi Shingai, Olivia K Donau, Ronald J Plishka, et al.
Nature|April 21, 2022
Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boostFrauke Muecksch, Zijun Wang, Alice Cho, et al.
The Journal of Experimental Medicine|July 1, 2022
Antibody evolution to SARS-CoV-2 after single-dose Ad26.COV2.S vaccine in humansAlice Cho, Frauke Muecksch, Zijun Wang, et al.
The Journal of Experimental Medicine|April 8, 2021
Broad and potent neutralizing human antibodies to tick-borne flaviviruses protect mice from diseaseMarianna Agudelo, Martin Palus, Jennifer R Keeffe, et al.
Pageof 11